SA119400353B1 - مشتق بيرازول مستبدل - Google Patents

مشتق بيرازول مستبدل

Info

Publication number
SA119400353B1
SA119400353B1 SA119400353A SA119400353A SA119400353B1 SA 119400353 B1 SA119400353 B1 SA 119400353B1 SA 119400353 A SA119400353 A SA 119400353A SA 119400353 A SA119400353 A SA 119400353A SA 119400353 B1 SA119400353 B1 SA 119400353B1
Authority
SA
Saudi Arabia
Prior art keywords
pyrazole derivative
substituted pyrazole
substituted
derivative
compound
Prior art date
Application number
SA119400353A
Other languages
English (en)
Inventor
عبدالرحمن العمر محمد
محمود حسن خليفه ناجي
Original Assignee
جامعة الملك سعود
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by جامعة الملك سعود filed Critical جامعة الملك سعود
Publication of SA119400353B1 publication Critical patent/SA119400353B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

يتعلق الاختراع الحالي بمشتق بيرازول مستبدل substituted pyrazole derivative يتضمن مركب بالصيغة: أو ملح مقبول صيدليا منه a pharmaceutically acceptable salt thereof.
SA119400353A 2018-01-15 2019-01-09 مشتق بيرازول مستبدل SA119400353B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/871,943 US10039749B1 (en) 2018-01-15 2018-01-15 Substituted pyrazole derivatives

Publications (1)

Publication Number Publication Date
SA119400353B1 true SA119400353B1 (ar) 2021-06-09

Family

ID=63013461

Family Applications (1)

Application Number Title Priority Date Filing Date
SA119400353A SA119400353B1 (ar) 2018-01-15 2019-01-09 مشتق بيرازول مستبدل

Country Status (2)

Country Link
US (1) US10039749B1 (ar)
SA (1) SA119400353B1 (ar)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146721A (en) 1969-09-12 1979-03-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrazol-4-acetic acid compounds
GB0419416D0 (en) 2004-09-01 2004-10-06 Inst Of Ex Botany Ascr 4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
WO2009145829A1 (en) 2008-04-01 2009-12-03 University Of Massachusetts Type iii secretion inhibitors, analogs and uses thereof
WO2010094009A2 (en) 2009-02-13 2010-08-19 Children's Hospital Medical Center Methods and compositions for the treatment of ras associated disorders
JP5419210B2 (ja) 2009-06-04 2014-02-19 国立大学法人山口大学 ゲル化剤
SI2772482T1 (sl) 2011-10-27 2016-06-30 Taisho Pharmaceutical Co., Ltd. Derivat azola

Also Published As

Publication number Publication date
US10039749B1 (en) 2018-08-07

Similar Documents

Publication Publication Date Title
PH12020500673A1 (en) Compounds
PH12015502031B1 (en) Tetrahydropyrrolothiazine compounds
PH12017501523A1 (en) Selective bace1 inhibitors
MX2020005818A (es) Triazol azoles de acido ciclohexilo como antagonistas de acido lisofosfatidico (lpa).
MX2022006783A (es) Nuevos derivados de metilquinazolinona.
MX2022014864A (es) Compuestos de bisamida que activan el sarcomero y sus usos.
MA40059A (fr) Inhibiteurs de la phosphatidylinositol 3-kinase
EP3871673A4 (en) NEW INDAZOLE COMPOUND OR SALT THEREOF
PH12016501517B1 (en) Tetrazolone-substituted dihydropyridinone mgat2 inhibitors
JOP20200030A1 (ar) مركب خماسي الحلقة
MX2015015841A (es) Compuestos de fenoxietil dihidro-1h-isoquinolina.
PH12018500282A1 (en) Cgrp receptor antagonists
MY193239A (en) Novel b-lactamase inhibitors
PH12019550154A1 (en) Azetidine derivative
PH12020550649A1 (en) Anti-hbv tetrahydroisoxazolo[4,3-c]pyridine compounds
MX2019001228A (es) Metodo de produccion del compuesto de pirazol-amida.
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
PH12021550601A1 (en) Tlr8 agonist
AU2019408336A8 (en) Phenylpyrrolidine compound and use thereof
MX2021009261A (es) Compuesto de fluorovinilbenzamida como inmunomodulador pd-l1.
SA119400353B1 (ar) مشتق بيرازول مستبدل
MX2018010652A (es) Composiciones farmaceuticas.
MX2022006984A (es) Procesos e intermediario para la preparacion de oxetan-2-ilmetanamina.
UA127754U (uk) Поліетергуанідингідрохлорид як бактерицидна речовина